Can nebulization cause heart attacks in infants? Here's what experts say

A growing number of pediatric specialists are urging parents to rethink the common practice of administering nebulization ...

U.S. FDA Approves PADCEV(R) plus Keytruda(R) for Certain Patients with Bladder Cancer

(TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has approved PADCEV (R) (enfortumab vedotin-ejfv), a Nectin-4 directed ...

Kura Oncology and Kyowa Kirin Announce FDA Approval of KOMZIFTI™ (ziftomenib), the First and Only Once-Daily Targeted Therapy for Adults with Relapsed or Refractory NPM1 ...

Kura Oncology will host a conference call on November 13, 2025, at 12:30 pm ET / 9:30 am PT – SAN DIEGO and TOYKO, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA) and Kyowa Kirin ...
Hosted on MSN

FDA issues urgent recall for mislabeled medication that could cause fatal overdoses

An urgent recall has been issued for a mislabeled medication used to treat a blood condition which could lead to fatal overdoses. Potassium chloride (KCl) injection is primarily used to treat and ...
EMBO Press

Artificial intelligence-enabled electrocardiography from scientific research to clinical application

Recent advancements in artificial intelligence (AI) have revolutionized the application of electrocardiography (ECG) in ...
Le Lézard

Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio

Bristol Myers Squibb today announced the presentation of more than 95 data disclosures, including 27 oral presentations, across company-sponsored studies and external collaborations at the 67th ...

Lilly to highlight progress across key programs in early and advanced hormone receptor-positive breast cancer at the 2025 San Antonio Breast Cancer Symposium

Eli Lilly and Company (NYSE: LLY) today announced that new data from across its breast oncology portfolio and pipeline will ...

Harmony Biosciences Announces Positive Results From the Pivotal Bioequivalence Study for Pitolisant Gastro-Resistant Formulation

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced positive results from its pivotal bioequivalence (BE) study evaluating pitolisant gastro-resistant (GR) formulation. With positive ...
Hosted on MSN

More than 20 million across the Ohio and Tennessee Valleys under severe storm threat on Friday

More than 20 million Americans are under severe storm threats as gulf moisture is expected to clash with a cold front in the Tennessee Valley ahead of the invasion of Arctic air next week. Senate to ...
KEYT

Your home has a 1 in 4 chance of being at severe risk from extreme weather

Extreme weather disasters — made larger, longer, and more intense by climate change — are taking a heavier toll on the possession that many Americans consider to be their most important asset: the ...

Fennec Pharmaceuticals Inc.: Fennec Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update

Q3 2025 Total Net Product Sales of $12.5 Million, 79% Year Over Year Growth ~ ~ Q3 2025 Positive Cash Flow from Operations, Cash Position Grew to $22 Million ~ ~ Japan Clinical Trial (STS-J01) Prelimi ...